From Featured Guest: Larry Jasinski, CEO of ReWalk robotic exoskeletons · · Bonati Spine Institute
“The unit that you take home right now is priced at $69,500 and uh we are doing two things we are providing data on on what it saves to the insurance company so we believe uh that this will save money to the Healthcare System uh and we are working extensively with different groups to get reimbursed on this.”
On , Larry Jasinski, CEO at Lifeward, spoke about healthcare costs during Featured Guest: Larry Jasinski, CEO of ReWalk robotic exoskeletons on Bonati Spine Institute.
Larry Jasinski, CEO of Lifeward (formerly ReWalk), discussed the company's progress and financial outlook in a July 2025 interview at THE ISRAEL CONFERENCE. He stated that the company's revenue for the year would be between $28 million and $30 million, and that it would reach break-even at around $40 million in revenue. Jasinski noted that after five years of effort, the company's exoskeleton technology became covered by insurance in April of the previous year, and that the company is working to secure coverage from private insurers. In a 2014 interview, Jasinski said the ReWalk exoskeleton for home use was priced at $69,500. He stated that the company was providing data to insurance companies on cost savings to the healthcare system and working with various groups to obtain reimbursement. Jasinski also noted that the Veterans Administration's James J. Peters VA Medical Center in the Bronx had issued a policy statement agreeing to pay for the device for eligible veterans.